Delivery Order SPE2DX22D0010-SPE2D825FHF29
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company Amerisourcebergen Corporation. The $3,829.90 contract requires the delivery of Percocet tablets to a location in Conshohocken, Pennsylvania by February 1, 2024. This delivery order was issued under an indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which...
- This is a $20,488.39 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,565,316,244 Percocet tablets (10/325 mg) by August 2, 2024. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 10/325 mg Percocet tablets. The order has a potential value of $15,319.60 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Percocet tablets 10/325mg, with a ceiling value of $40,711.25 and a completion date of July 9, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,684.75, is for the delivery of Percocet tablets (10/325 mg) and has a completion date of February 27, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Percocet tablets (10/325 mg) to the U.S. government. The contract is a Delivery Order with a Firm Fixed Price of $37,395.50 and a performance period ending on May 27, 2025. The contract was awarded on May 23, 2025 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen is the prime contractor, and there is no set-aside designation, indicating open competition....
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $50,334.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Percocet tablets (10/325 mg) with an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,049.71, is a delivery order for the supply of Percocet tablets (10/325 mg) to support federal healthcare programs. The contract has an ultimate completion date of October 16, 2024 and is a firm fixed-price arrangement. Amerisourcebergen has been awarded numerous federal contracts and Indefinite Delivery...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $29,175.70, is for the provision of Percocet tablets (10 mg/325 mg). This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor, for the supply of Percocet 10-325 mg tablets. The award has a ceiling value of $139,822.85 and a period of performance through April 4, 2024. It is a firm fixed price contract. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This award is a task order under a larger...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHF29Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Percocet Tablets (10/325 mg) with a ceiling value of $23,778.44. This competitively awarded, firm fixed-price delivery order is classified as a child contract and represents a non-set-aside procurement. The place of performance is located at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a broad spectrum of pharmaceutical products and medical commodities to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates consistent capability in fulfilling competitive federal medical supply requirements across multiple therapeutic domains through delivery orders with firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.8k | 7/28/25 |